111 filings
8-K
CTMX
CytomX Therapeutics Inc
17 May 24
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
CTMX
CytomX Therapeutics Inc
8 May 24
CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for
4:41pm
8-K
CTMX
CytomX Therapeutics Inc
8 May 24
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
4:04pm
8-K
CTMX
CytomX Therapeutics Inc
22 Mar 24
Departure of Directors or Certain Officers
4:06pm
8-K
CTMX
CytomX Therapeutics Inc
11 Mar 24
CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
4:02pm
8-K
izf8xb
7 Nov 23
CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:05pm
8-K
57q0f
24 Aug 23
Entry into a Material Definitive Agreement
4:05pm
8-K
x9axg4gesoybwza5sm
8 Aug 23
CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
4:08pm
8-K
3kgndmik
30 Jun 23
Entry into a Material Definitive Agreement
7:07pm
8-K
ja6 s6ipkx
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
qdtiw
9 May 23
CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:12pm
8-K
gfnx0k
27 Mar 23
CytomX Therapeutics Reports Full Year 2022 Financial Results
4:13pm
8-K
ch3pml
10 Mar 23
Regulation FD Disclosure
3:36pm
8-K
3hs w7rv0p
24 Feb 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
7:00am
8-K
43w6sb
5 Jan 23
Entry into a Material Definitive Agreement
4:13pm
8-K
zsydahhltqdonc462
21 Nov 22
Entry into a Material Definitive Agreement
8:05pm
8-K
0gwo19dt
8 Nov 22
CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
4:09pm
8-K
bwg g5fq2
23 Sep 22
Departure of Directors or Certain Officers
4:07pm
8-K
mfghm
13 Sep 22
Departure of Directors or Certain Officers
4:11pm
8-K
vp0des alwuw
4 Aug 22
CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
4:12pm